| Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964) |
|---|
| 06/19/2007 | US7232680 For producing vaccine for protecting a mammal or a bird from infection by a Nidovirales virus |
| 06/19/2007 | US7232566 Methods for treating HIV infected subjects |
| 06/19/2007 | CA2287478C Methods for increasing the efficiency of recombinant aav product |
| 06/14/2007 | WO2007067733A2 Compositions and methods to monitor rna delivery to cells |
| 06/14/2007 | WO2007067597A2 Methods and compositions for needleless delivery of binding partners |
| 06/14/2007 | WO2007067561A2 Porous calcium phosphate bone material |
| 06/14/2007 | WO2007067517A2 Dsrnas as influenza virus vaccine adjuvants or immuno-stimulants |
| 06/14/2007 | WO2007066423A1 Tumor antigen peptide derived from amacr |
| 06/14/2007 | WO2007065690A1 Compositions and methods for therapy and diagnosis of cancer |
| 06/14/2007 | WO2007048244A3 Small interfering ribonucleic acid duplexes comprising arabinose modified nucleotides |
| 06/14/2007 | WO2007017212A3 Use of an active biological substance in abnormal cellular and viral membrane physiologies |
| 06/14/2007 | WO2006048768A8 Kit of parts designed for implementing an antitumoral or antiviral treatment in a mammal |
| 06/14/2007 | WO2006002262A3 Genes and pathways differentially expressed in bipolar disorder and/or major depressive disorder |
| 06/14/2007 | WO2004043335A3 Methods of treating infection by drug resistant bacteria |
| 06/14/2007 | US20070136833 Genes encoding several poly (ADP-RIBOSE) glycohydrolase (PARG) enzymes, the proteins and fragments thereof, and antibodies immunoreactive therewith |
| 06/14/2007 | US20070136828 Methods of using molecules related to organic cation transporter 3 (oct3) for treating depression, anxiety neuroses, drug dependencies, and other similar mental disorders |
| 06/14/2007 | US20070135373 Method for selective expression of therapeutic genes by hyperthermia |
| 06/14/2007 | US20070135372 Modified siRNA molecules and uses thereof |
| 06/14/2007 | US20070135371 Antisense IAP nucleobase oligomers and uses thereof |
| 06/14/2007 | US20070135370 siRNA molecule for silencing Ebola virus L-polymerase (L-pol) expression; nucleic acid-lipid particles suitable for use in intravenous nucleic acid delivery as they are stable in circulation, of a size required for pharmacodynamic behavior resulting in access to extravascular sites, and target cell |
| 06/14/2007 | US20070135369 Methods of modulating angiogenesis and screening compounds for activity in modulating angiogenesis |
| 06/14/2007 | US20070135368 Cell-to-cell transmission of siRNA induced gene silencing in mammalian cells |
| 06/14/2007 | US20070135367 Method for controlling sr protein phosphorylation, and antiviral agents whose active ingredients comprise agents that control sr protein activity |
| 06/14/2007 | US20070135366 evaluating the amount of cancer cells existing in pancreatic cells or tissues, by measuring the methylation frequency of Fibrillin2 gene or an index value having the correlation therewith, and comparing with a control; medical diagnosis |
| 06/14/2007 | US20070135365 Pharmaceutical composition for preventing or remedying cardiac hypertrophy and cardiovascular disease caused thereby |
| 06/14/2007 | US20070135364 Compositions and methods for the modulation of the expression of b7 protein |
| 06/14/2007 | US20070135340 IGF-1 novel peptides |
| 06/14/2007 | US20070135335 Therapeutic molecules |
| 06/14/2007 | US20070135333 An antibacterial antisense oligonucleotide conjugated to a carrierpeptide that significantly enhances the antibacterial activity of the oligonucleotide; a targeting nucleic acid sequence complementary to a target sequence of the translational start codon of a bacterial mRNA |
| 06/14/2007 | US20070134761 Minimal dna sequence acting as a chromatin insulator and its use in protein expression |
| 06/14/2007 | US20070134735 Transcriptional regulation of the human beta3-adrenergic receptor gene |
| 06/14/2007 | US20070134674 Method for the prognosis and/or diagnosis of a cancer |
| 06/14/2007 | US20070134654 Means for use in treating diseases correlated with or caused by non-physiological levels of microtubule-associated pp2ac |
| 06/14/2007 | US20070134650 Scleraxis |
| 06/14/2007 | US20070134332 Polymer particles for delivery of macromolecules and methods of use |
| 06/14/2007 | US20070134274 Vaccine candidates against Johne's disease |
| 06/14/2007 | US20070134273 Composition and method for the treatment of carcinoma |
| 06/14/2007 | US20070134258 Gasp1: a follistatin domain containing protein |
| 06/14/2007 | US20070134253 Serpentine transmembrane epithelial antigens of the prostate; polynucleotides, recombinant expression vectors, and host cells; anticarcinogenic agents; diagnosis and prognosis of urogenital and bone cancers and lymphomas |
| 06/14/2007 | US20070134250 Composition Comprising and Method of Using Angiopoietin-Like Protein 3 ANGPTL3 |
| 06/14/2007 | US20070134239 Nucleotide and protein sequences of vertebrate delta genes and methods based thereon |
| 06/14/2007 | US20070134238 Modulation of T Cell Differentiation for the Treatment of T Helper Cell Mediated Diseases |
| 06/14/2007 | US20070134219 Antigen presenting cells; immunogens |
| 06/14/2007 | US20070134218 Using LIM mineralization protein expression as tool for enhancing glycoprotein expression in cells; tissue engineering and regenerative medicine |
| 06/14/2007 | US20070134217 Using transposon vector as gene transfer and amplification tool; gene therapy |
| 06/14/2007 | US20070134216 Formed by combining an implantable bone structure configured to form an internal cavity and a semi-permeable membrane such that an internal cavity is maintained; for delivering one or more biologically active molecules and/or one or more living cells or tissues to a subject |
| 06/14/2007 | US20070134215 Using mammalian pluripotent stem cells to generate cardiomyocytes for use in treatment of heart disease |
| 06/14/2007 | US20070134214 Inactivated host cell delivery of polynucleotides encoding immunogens |
| 06/14/2007 | US20070134213 Reversibly immortalised olfactory ensheathing glia and their use to promote neuronal regeneration |
| 06/14/2007 | US20070134212 Engrafting foreign replacement cells within fetal non-human mammal by selectively destroying native cells in tissue of fetal non-human mammal host, wherein number of maternal cells of same tissue is not substantially reduced; thereafter implanting foreign replacement cells in tissue of fetal mammal host |
| 06/14/2007 | US20070134211 Differentiation of adipose stromal cells into osteoblasts and uses thereof |
| 06/14/2007 | US20070134206 Targeting proteins to deliver therapeutic or diagnostic reagents |
| 06/14/2007 | US20070134205 Gene delivery of detoxifying agent |
| 06/14/2007 | US20070134204 Method for treating nerve injury and vector construct for the same |
| 06/14/2007 | US20070134203 Compositions and methods for increasing packaging and yields of recombinant adenoviruses using multiple packaging signals |
| 06/14/2007 | US20070134202 Cancer gene therapeutic drug |
| 06/14/2007 | US20070134201 Archaeon expression system |
| 06/14/2007 | US20070134200 Immunogenic composition and methods |
| 06/14/2007 | US20070134188 Double-stranded RNA oligonucleotides which inhibit tyrosinase expression |
| 06/14/2007 | US20070134169 Methods for smoking cessation or alcohol cessation or other addiction cessation |
| 06/14/2007 | DE10297513B4 In vitro Herstellung von dendritischen Zellen aus CD14+ Monocyten In vitro production of dendritic cells from CD14 + monocytes |
| 06/14/2007 | CA2630904A1 Compositions and methods for therapy and diagnosis of cancer |
| 06/13/2007 | EP1795598A1 Novel peptides |
| 06/13/2007 | EP1795596A1 Composition and methods for therapy and diagnosis of cancer |
| 06/13/2007 | EP1795593A1 Target nucleic acid of retrovirus integration |
| 06/13/2007 | EP1795539A1 Cell penetrating peptides for intracellular delivery of molecules |
| 06/13/2007 | EP1795206A1 Drug for treating or preventing hcv infection |
| 06/13/2007 | EP1795203A2 Fhit proteins and nucleic acids and methods based thereon |
| 06/13/2007 | EP1794322A2 Klf6 alternative splice forms and a germline klf6 dna polymorphism associated with increased cancer risk |
| 06/13/2007 | EP1363932B1 Amphoteric sterols and the use thereof |
| 06/13/2007 | EP1339737B1 Immunomodulatory protein derived from the yaba monkey tumor virus |
| 06/13/2007 | EP1335926B1 Method of separating extra-chromosomal dna from other cellular components |
| 06/13/2007 | EP1302542B1 Novel physiologically active peptide and use thereof |
| 06/13/2007 | EP1230349B1 Nucleic acids encoding endotheliases, endotheliases and uses thereof |
| 06/13/2007 | EP1220679B1 Cell-based gene therapy for the pulmonary system |
| 06/13/2007 | EP1176870B1 Tgf-alpha polypeptides, functional fragments and methods of use therefor |
| 06/13/2007 | EP1140969B1 Connective tissue growth factor fragments and methods and uses thereof |
| 06/13/2007 | EP1100895B1 Abc1 polypeptide and methods and reagents for modulating cholesterol levels |
| 06/13/2007 | EP1037989B1 Nucleotide and protein sequence of mammastatin and methods of use |
| 06/13/2007 | EP1027429B1 Jnk3 modulators and methods of use |
| 06/13/2007 | EP1011457B1 Stent lining |
| 06/13/2007 | EP0986572B2 Immunostimulatory oligonucleotides, compositions thereof and methods of use thereof |
| 06/13/2007 | EP0792278B1 Tumor necrosis factor-gamma |
| 06/13/2007 | CN1981044A Lipid encapsulated interfering RNA |
| 06/13/2007 | CN1981043A Recombinant lentiviral vector for expression of a flaviviridae protein and applications thereof as a vaccine |
| 06/13/2007 | CN1981040A Recombinant virus vector for gene introduction in lymphocyte |
| 06/13/2007 | CN1981032A A novel strain of sars-associated coronavirus and use thereof |
| 06/13/2007 | CN1980699A Treatment methods utilizing albumin-binding proteins as targets |
| 06/13/2007 | CN1980686A Antiobesity drug |
| 06/13/2007 | CN1980683A Use of lactic acid bacteria for decreasing gum bleeding and reducing oral inflammation |
| 06/13/2007 | CN1980573A Lentiviral vector delivery of native and mutated IGFBP-3 for treatment of cancer |
| 06/13/2007 | CN1977976A Method for treating nerve injury and vector construct for the same |
| 06/13/2007 | CN1321182C Full gene cloning of horse infectious anemia virus representating virus strain and its use |
| 06/13/2007 | CN1321131C Pig Ghrelin derivative, its encoding gene and application |
| 06/13/2007 | CN1320929C Agents for gene therapeutic for cerebrovascular disorders |
| 06/12/2007 | US7230155 Method for identifying an agonist of neuronal calcium sensor-1 (NCS-1), for therapy of CNS disorders |
| 06/12/2007 | US7229975 DNA immunization against chlamydia infection |
| 06/12/2007 | US7229823 Methods for increasing the efficiency of recombinant AAV product |
| 06/12/2007 | US7229770 YKL-40 as a marker and prognostic indicator for cancers |
| 06/12/2007 | US7229625 Retrovirus-like particles made non-infectious by a plurality of mutations |